Interferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on Siglec-1/CD169
- PMID: 23593001
- PMCID: PMC3623718
- DOI: 10.1371/journal.ppat.1003291
Interferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on Siglec-1/CD169
Abstract
Human immunodeficiency virus type 1 (HIV-1) interactions with myeloid dendritic cells (DCs) can result in virus dissemination to CD4⁺ T cells via a trans infection pathway dependent on virion incorporation of the host cell derived glycosphingolipid (GSL), GM3. The mechanism of DC-mediated trans infection is extremely efficacious and can result in infection of multiple CD4⁺ T cells as these cells make exploratory contacts on the DC surface. While it has long been appreciated that activation of DCs with ligands that induce type I IFN signaling pathway dramatically enhances DC-mediated T cell trans infection, the mechanism by which this occurs has remained unclear until now. Here, we demonstrate that the type I IFN-inducible Siglec-1, CD169, is the DC receptor that captures HIV in a GM3-dependent manner. Selective downregulation of CD169 expression, neutralizing CD169 function, or depletion of GSLs from virions, abrogated DC-mediated HIV-1 capture and trans infection, while exogenous expression of CD169 in receptor-naïve cells rescued GSL-dependent capture and trans infection. HIV-1 particles co-localized with CD169 on DC surface immediately following capture and subsequently within non-lysosomal compartments that redistributed to the DC--T cell infectious synapses upon initiation of T cell contact. Together, these findings describe a novel mechanism of pathogen parasitization of host encoded cellular recognition machinery (GM3--CD169 interaction) for DC-dependent HIV dissemination.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Virus particle release from glycosphingolipid-enriched microdomains is essential for dendritic cell-mediated capture and transfer of HIV-1 and henipavirus.J Virol. 2014 Aug;88(16):8813-25. doi: 10.1128/JVI.00992-14. Epub 2014 May 28. J Virol. 2014. PMID: 24872578 Free PMC article.
-
Interferon-Inducible CD169/Siglec1 Attenuates Anti-HIV-1 Effects of Alpha Interferon.J Virol. 2017 Oct 13;91(21):e00972-17. doi: 10.1128/JVI.00972-17. Print 2017 Nov 1. J Virol. 2017. PMID: 28794041 Free PMC article.
-
CD169-mediated trafficking of HIV to plasma membrane invaginations in dendritic cells attenuates efficacy of anti-gp120 broadly neutralizing antibodies.PLoS Pathog. 2015 Mar 11;11(3):e1004751. doi: 10.1371/journal.ppat.1004751. eCollection 2015 Mar. PLoS Pathog. 2015. PMID: 25760631 Free PMC article.
-
CD169-dependent cell-associated HIV-1 transmission: a driver of virus dissemination.J Infect Dis. 2014 Dec 15;210 Suppl 3(Suppl 3):S641-7. doi: 10.1093/infdis/jiu442. J Infect Dis. 2014. PMID: 25414418 Free PMC article. Review.
-
HIV-1 capture and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1.PLoS Pathog. 2014 Jul 17;10(7):e1004146. doi: 10.1371/journal.ppat.1004146. eCollection 2014 Jul. PLoS Pathog. 2014. PMID: 25033082 Free PMC article. Review.
Cited by
-
Viruses exploit the tissue physiology of the host to spread in vivo.Curr Opin Cell Biol. 2016 Aug;41:81-90. doi: 10.1016/j.ceb.2016.04.008. Epub 2016 May 3. Curr Opin Cell Biol. 2016. PMID: 27149407 Free PMC article. Review.
-
When Dendritic Cells Go Viral: The Role of Siglec-1 in Host Defense and Dissemination of Enveloped Viruses.Viruses. 2019 Dec 19;12(1):8. doi: 10.3390/v12010008. Viruses. 2019. PMID: 31861617 Free PMC article. Review.
-
Negative and Positive Selection Pressure During Sexual Transmission of Transmitted Founder HIV-1.Front Immunol. 2019 Jul 10;10:1599. doi: 10.3389/fimmu.2019.01599. eCollection 2019. Front Immunol. 2019. PMID: 31354736 Free PMC article. Review.
-
Actin-regulated Siglec-1 nanoclustering influences HIV-1 capture and virus-containing compartment formation in dendritic cells.Elife. 2023 Mar 20;12:e78836. doi: 10.7554/eLife.78836. Elife. 2023. PMID: 36940134 Free PMC article.
-
Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells/mm3 results in differential recovery of monocyte activation.J Leukoc Biol. 2016 Jul;100(1):223-31. doi: 10.1189/jlb.5AB0915-406R. Epub 2015 Nov 25. J Leukoc Biol. 2016. PMID: 26609048 Free PMC article.
References
-
- Cameron PU, Freudenthal PS, Barker JM, Gezelter S, Inaba K, et al. (1992) Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science 257: 383–387. - PubMed
-
- McDonald D, Wu L, Bohks SM, KewalRamani VN, Unutmaz D, et al. (2003) Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300: 1295–1297. - PubMed
-
- Turville SG, Cameron PU, Handley A, Lin G, Pohlmann S, et al. (2002) Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol 3: 975–983. - PubMed
-
- Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, et al. (2000) DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100: 587–597. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
